Xoma | XOMA - Capitale Ordinario



Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 38.52M 3.2M 2026-03
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Ardelyx USD 246.97M 2.62M 2026-03
aTyr Pharma USD 62.99M 46.35M 2026-03
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Celldex Therapeutics USD 78.5M 11.93M 2026-06
Curis USD 2M 10.93M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Emergent BioSolutions USD 100K 0 2023-06
Incyte USD 200.98M 1.03M 2026-06
MacroGenics USD 63.56M 241K 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 0 2026-06
Prothena USD 53.08M 756K 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03